Loading...
Loading...
BG Medicine
BGMD, a company focused on the development and commercialization of
novel cardiovascular diagnostics, announced today that it has appointed
Charles H. Abdalian, Jr., as the company's Executive Vice President, Chief
Financial Officer. Mr. Abdalian most recently held the position of Vice
President and Chief Financial Officer of Knome, Inc., a bioinformatics company
providing human genome interpretation software and services to international
bio/pharma companies, leading academic institutions and molecular diagnostics
labs.
"We are pleased to welcome Chuck to the CFO role," said Eric Bouvier,
President and Chief Executive Officer of BG Medicine, Inc. "As the Company
enters its next phase of growth, Chuck brings over thirty years of experience
in Healthcare corporate finance and strategic management which will provide us
with key insights into successfully creating value as we advance our products
in the global marketplace."
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: NewsManagement
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in